1. Home
  2. CDNA vs ARCB Comparison

CDNA vs ARCB Comparison

Compare CDNA & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$66.83

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Logo ArcBest Corporation

ARCB

ArcBest Corporation

N/A

Current Price

$129.52

Market Cap

3.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNA
ARCB
Founded
1998
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2007
1994

Fundamental Metrics

Financial Performance
Metric
CDNA
ARCB
Price
$66.83
$129.52
Analyst Decision
Buy
Buy
Analyst Count
7
14
Target Price
$58.83
★ $170.92
AVG Volume (30 Days)
★ 1.0M
176.4K
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
★ 0.38%
EPS Growth
N/A
★ N/A
EPS
★ 2.13
N/A
Revenue
$48,324,000.00
★ $1,657,864,000.00
Revenue This Year
$30.36
$12.05
Revenue Next Year
$6.23
$7.67
P/E Ratio
$30.04
★ N/A
Revenue Growth
★ 18.93
12.56
52 Week Low
$13.95
$59.43
52 Week High
$65.50
$176.69

Technical Indicators

Market Signals
Indicator
CDNA
ARCB
Relative Strength Index (RSI) 78.88 39.11
Support Level $17.26 $115.28
Resistance Level N/A $142.33
Average True Range (ATR) 2.87 4.01
MACD 0.90 -0.13
Stochastic Oscillator 99.39 20.19

Price Performance

Historical Comparison
CDNA
ARCB

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: